Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1986 Nov 1;239(3):537–543. doi: 10.1042/bj2390537

Renal plasma membrane receptors for certain modified serum albumins. Evidence for participation of a heparin receptor.

P N Ranganathan, J L Mego
PMCID: PMC1147320  PMID: 3030264

Abstract

Binding of formaldehyde-treated (f-alb), reduced-carboxymethylated (ac-alb) or reduced-acetamidated (am-alb) bovine serum albumins to purified rat renal plasma membranes was studied. Radioiodinated f-alb or ac-alb bound to kidney membranes while am-alb neither bound significantly nor competed with f-alb binding to kidney membranes. The binding was specific, saturable and heat- and proteinase-sensitive. Competition studies showed that f-alb and ac-alb sites may be the same on these membranes. To determine the role played by charge in binding, competition experiments with polyanions were performed. Polyanions such as nucleic acid or glycosaminoglycans were effective competitors of f-alb binding to cell membranes. Heparin was especially inhibitory, being several-fold more so than chondroitin sulphate. Completely reduced and carboxymethylated albumin was a better competitor than its partially modified counterpart. Furthermore, f-alb was a significant competitor of [35S]heparin binding to kidney membranes. Also, partially purified heparin receptor demonstrated specific binding of 125I-f-alb. These data suggest that a heparin receptor is responsible for binding and internalization of intravenously injected f-alb. A Scatchard plot revealed two classes of receptors with dissociation constants of 3.2 X 10(-6) M and 4.7 X 10(-5) M.

Full text

PDF
537

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assimacopoulos-Jeannet F., Cantau B., van de Werve G., Jard S., Jeanrenaud B. Lack of vasopressin receptors in liver, but not in kidney, of ob/ob mice. Biochem J. 1983 Nov 15;216(2):475–480. doi: 10.1042/bj2160475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Basu S. K., Goldstein J. L., Anderson G. W., Brown M. S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3178–3182. doi: 10.1073/pnas.73.9.3178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blomhoff R., Drevon C. A., Eskild W., Helgerud P., Norum K. R., Berg T. Clearance of acetyl low density lipoprotein by rat liver endothelial cells. Implications for hepatic cholesterol metabolism. J Biol Chem. 1984 Jul 25;259(14):8898–8903. [PubMed] [Google Scholar]
  4. Blomhoff R., Eskild W., Berg T. Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cells. Biochem J. 1984 Feb 15;218(1):81–86. doi: 10.1042/bj2180081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown M. S., Basu S. K., Falck J. R., Ho Y. K., Goldstein J. L. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramol Struct. 1980;13(1):67–81. doi: 10.1002/jss.400130107. [DOI] [PubMed] [Google Scholar]
  6. Brown M. S., Goldstein J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223–261. doi: 10.1146/annurev.bi.52.070183.001255. [DOI] [PubMed] [Google Scholar]
  7. GOLDSTEIN I. J., HOLLERMAN C. E., SMITH E. E. PROTEIN-CARBOHYDRATE INTERACTION. II. INHIBITION STUDIES ON THE INTERACTION OF CONCANAVALIN A WITH POLYSACCHARIDES. Biochemistry. 1965 May;4:876–883. doi: 10.1021/bi00881a013. [DOI] [PubMed] [Google Scholar]
  8. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979 Jan;76(1):333–337. doi: 10.1073/pnas.76.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haberland M. E., Fogelman A. M., Edwards P. A. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci U S A. 1982 Mar;79(6):1712–1716. doi: 10.1073/pnas.79.6.1712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Horiuchi S., Takata K., Maeda H., Morino Y. Scavenger function of sinusoidal liver cells. Acetylated low-density lipoprotein is endocytosed via a route distinct from formaldehyde-treated serum albumin. J Biol Chem. 1985 Jan 10;260(1):53–56. [PubMed] [Google Scholar]
  11. Horiuchi S., Takata K., Morino Y. Characterization of a membrane-associated receptor from rat sinusoidal liver cells that binds formaldehyde-treated serum albumin. J Biol Chem. 1985 Jan 10;260(1):475–481. [PubMed] [Google Scholar]
  12. Horiuchi S., Takata K., Morino Y. Purification of a receptor for formaldehyde-treated serum albumin from rat liver. J Biol Chem. 1985 Jan 10;260(1):482–488. [PubMed] [Google Scholar]
  13. Kraemer F. B., Chen Y. D., Lopez R. D., Reaven G. M. Characterization of the binding site on thioglycolate-stimulated mouse peritoneal macrophages that mediates the uptake of very low density lipoproteins. J Biol Chem. 1983 Oct 25;258(20):12190–12197. [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. MEGO J. L., MCQUEEN J. D. THE UPTAKE AND DEGRADATION OF INJECTED LABELED PROTEINS BY MOUSE-LIVER PARTICLES. Biochim Biophys Acta. 1965 Apr 12;100:136–143. doi: 10.1016/0304-4165(65)90436-8. [DOI] [PubMed] [Google Scholar]
  16. MERGENTHALER D. D., PAFF G. H. Peritoneal mast cells as a possible source of circulating heparin in the rat. Anat Rec. 1956 Oct;126(2):165–175. doi: 10.1002/ar.1091260204. [DOI] [PubMed] [Google Scholar]
  17. Mego J. L., Bertini F., McQueen J. D. The use of formaldehyde-treated 131-I-albumin in the study of digestive vacuoles and some properties of these particles from mouse liver. J Cell Biol. 1967 Mar;32(3):699–707. doi: 10.1083/jcb.32.3.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mego J. L., McQueen J. D. The uptake of labeled proteins by particulate fractions of tumor and normal tissues after injection into mice. Cancer Res. 1965 Jul;25(6):865–869. [PubMed] [Google Scholar]
  19. Mego J. L. Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin. Biochem J. 1984 Mar 15;218(3):775–783. doi: 10.1042/bj2180775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mego J. L. The effect of pH on cathepsin activities in mouse liver heterolysosomes. Biochem J. 1971 May;122(4):445–452. doi: 10.1042/bj1220445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moore A. T., Williams K. E., Lloyd J. B. The effect of chemical treatments of albumin and orosomucoid on rate of clearance from the rat bloodstream and rate of pinocytic capture of rat yolk sac cultured in vitro. Biochem J. 1977 Jun 15;164(3):607–616. doi: 10.1042/bj1640607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nagelkerke J. F., Barto K. P., van Berkel T. J. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem. 1983 Oct 25;258(20):12221–12227. [PubMed] [Google Scholar]
  23. Nilsson M., Berg T. Uptake and degradation of formaldehyde-treated 125I-labelled human serum albumin in rat liver cells in vivo and in vitro. Biochim Biophys Acta. 1977 Mar 29;497(1):171–182. doi: 10.1016/0304-4165(77)90150-7. [DOI] [PubMed] [Google Scholar]
  24. SERAFIN J. Some aspects in the biochemical method for heparin assay: a modified method for the metachromatic assay of heparin. Am J Med Technol. 1957 May-Jun;23(3):171–177. [PubMed] [Google Scholar]
  25. Stremmel W., Potter B. J., Berk P. D. Studies of albumin binding to rat liver plasma membranes. Implications for the albumin receptor hypothesis. Biochim Biophys Acta. 1983 Mar 15;756(1):20–27. doi: 10.1016/0304-4165(83)90019-3. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES